CoChat

The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models

Open access
Ma, Qiu-Lan, Zhu, Cansheng, Morselli, Marco, Su, Trent, Pelligrini, Matteo, Lu, Zhengqi, Jones, Mychica, Denver, Paul, Castro, Daniel, Gu, Xuelin, Relampagos, Frances, Caoili, Kaitlin, Teter, Bruce, Frautschy, Sally A., Cole, Gregory M. · 2020 · Frontiers in Immunology
Cited by 48

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Neuroinflammation plays a crucial role in the development and progression of Alzheimer’s disease (AD), in which activated microglia are found to be associated with neurodegeneration. However, there is limited evidence showing how neuroinflammation and activated microglia are directly linked to neurodegeneration in vivo. Besides, there are currently no effective anti-inflammatory drugs for AD. In this study, we report on an effective anti-inflammatory lipid, linoleic acid (LA) metabolite docosapentaenoic acid (DPAn-6) treatment of aged humanized EFAD mice with advanced AD pathology. We also report the associations of neuroinflammatory and/or activated microglial markers with neurodegeneration in vivo. First, we found that dietary LA reduced proinflammatory cytokines of IL1-, IL-6, as well as mRNA expression of COX2 towards resolving neuroinflammation with an increase of IL-10 in adult AD models E3FAD and E4FAD mice. Brain fatty acid assays showed a five to six-fold increase in DPAn-6 by dietary LA, especially more in E4FAD mice, when compared to standard diet. Thus, we tested DPAn-6 in aged E4FAD mice. After DPAn-6 was administered to the E4FAD mice by oral gavage for three weeks, we found that DPAn-6 reduced microgliosis and mRNA expressions of inflammatory, microglial, and caspase markers. Further, DPAn-6 increased mRNA expressions of ADCYAP1, VGF, and neuronal pentraxin 2 in parallel, all of which were inversely correlated with inflammatory and microglial markers. Finally, both LA and DPAn-6 directly reduced mRNA expression of COX2 in amyloid-beta42 oligomer-challenged BV2 microglial cells. Together, these data indicated that DPAn-6 modulated neuroinflammatory responses towards resolution and improvement of neurodegeneration in the late stages of AD models.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2020.558036

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 50

  1. Guerreiro, 2013, TREM2 variants in Alzheimer's disease, N Engl J Med., 368, 117, 10.1056/NEJMoa1211851 · DOI · Paper page
  2. Jonsson, 2013, Variant of TREM2 associated with the risk of Alzheimer's disease, N Engl J Med., 368, 107, 10.1056/NEJMoa1211103 · DOI · Paper page
  3. Malik, 2013, CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing, J Neurosci., 33, 13320, 10.1523/JNEUROSCI.1224-13.2013 · DOI · Paper page
  4. Keren-Shaul, 2017, A unique microglia type associated with restricting development of Alzheimer's Disease, Cell., 169, 1276, 10.1016/j.cell.2017.05.018 · DOI · Paper page
  5. Migliore, 2009, Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases, Mutat Res., 667, 82, 10.1016/j.mrfmmm.2008.10.011 · DOI · Paper page
  6. Lim, 2000, Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease, J Neurosci., 20, 5709, 10.1523/JNEUROSCI.20-15-05709.2000 · DOI · Paper page
  7. Zarghi, 2011, Selective COX-2 inhibitors: a review of their structure-activity relationships, Iran J Pharm Res., 10, 655
  8. Miguel-Alvarez, 2015, Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect, Drugs Aging., 32, 139, 10.1007/s40266-015-0239-z · DOI · Paper page
  9. Miyata, 2015, Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases, Allergol Int., 64, 27, 10.1016/j.alit.2014.08.003 · DOI · Paper page
  10. Schwanke, 2016, EPA- and DHA-derived resolvins' actions in inflammatory bowel disease, Eur J Pharmacol., 785, 156, 10.1016/j.ejphar.2015.08.050 · DOI
  11. Navarro-Xavier, 2016, Protective effect of soybean oil- or fish oil-rich diets on allergic airway inflammation, J Inflamm Res., 9, 79, 10.2147/JIR.S102221 · DOI
  12. Hamanaka, 2000, Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice, Human Mol Gen., 9, 353, 10.1093/hmg/9.3.353 · DOI · Paper page
  13. Lim, 2005, A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model, J Neurosci., 25, 3032, 10.1523/JNEUROSCI.4225-04.2005 · DOI · Paper page
  14. Moriguchi, 2000, Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration, J Neurochem., 75, 2563, 10.1046/j.1471-4159.2000.0752563.x · DOI · Paper page
  15. Calon, 2004, Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model, Neuron., 43, 633, 10.1016/j.neuron.2004.08.013 · DOI · Paper page
  16. Yang, 1998, Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease, Am J Pathol., 152, 379
  17. Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics., 29, 15, 10.1093/bioinformatics/bts635 · DOI · Paper page
  18. Law, 2014, voom: Precision weights unlock linear model analysis tools for RNA-seq read counts, Genome Biol., 15, R29, 10.1186/gb-2014-15-2-r29 · DOI · Paper page
  19. Law, 2016, RNA-seq analysis is easy as 1-2-3 with limma, Glimma and edgeR, F1000Res., 5, 2, 10.12688/f1000research.9005.2 · DOI · Paper page
  20. Zhang, 2019, Novel data transformations for RNA-seq differential expression analysis, Sci Rep., 9, 4820, 10.1038/s41598-019-41315-w · DOI
  21. Costa-Silva, 2017, RNA-Seq differential expression analysis: An extended review and a software tool, PLoS ONE., 12, e0190152, 10.1371/journal.pone.0190152 · DOI · Paper page
  22. Saini, 2018, Omega-3 and omega-6 polyunsaturated fatty acids: dietary sources, metabolism, and significance - A review, Life Sci., 203, 255, 10.1016/j.lfs.2018.04.049 · DOI · Paper page
  23. Innes, 2018, The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiometabolic risk factors: a systematic review, Int J Mol Sci., 19, 32, 10.3390/ijms19020532 · DOI · Paper page
  24. Xiong, 2014, Alzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain, J Alzheimers Dis., 40, 297, 10.3233/JAD-132081 · DOI · Paper page
  25. Hampel, 2005, Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain, Eur Arch Psychiatry Clin Neurosci., 255, 269, 10.1007/s00406-004-0558-2 · DOI
  26. Buchhave, 2010, Soluble TNF receptors are associated with Abeta metabolism and conversion to dementia in subjects with mild cognitive impairment, Neurobiol Aging., 31, 1877, 10.1016/j.neurobiolaging.2008.10.012 · DOI
  27. Li, 2004, Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death, J Neurosci., 24, 1760, 10.1523/JNEUROSCI.4580-03.2004 · DOI · Paper page
  28. Shouval, 2014, Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function, Immunity., 40, 706, 10.1016/j.immuni.2014.03.011 · DOI · Paper page
  29. Sudduth, 2013, Neuroinflammatory phenotype in early Alzheimer's disease, Neurobiol Aging., 34, 1051, 10.1016/j.neurobiolaging.2012.09.012 · DOI · Paper page
  30. D'Anna, 2017, Serum interleukin-10 levels correlate with cerebrospinal fluid amyloid beta deposition in alzheimer disease patients, Neurodegener Dis., 17, 227, 10.1159/000474940 · DOI
  31. Wang, 2003, Preliminary studies on Alzheimer's disease using cDNA microarrays, Mech Ageing Dev., 124, 115, 10.1016/S0047-6374(02)00188-4 · DOI
  32. Nauroth, 2010, Docosahexaenoic acid (DHA) and docosapentaenoic acid (DPAn-6) algal oils reduce inflammatory mediators in human peripheral mononuclear cells in vitro and paw edema in vivo, Lipids, 45, 375, 10.1007/s11745-010-3406-3 · DOI · Paper page
  33. Glenn, 1989, Further studies on the identification of microglia in mixed brain cell cultures, Brain Res Bull., 22, 1049, 10.1016/0361-9230(89)90018-X · DOI
  34. Glenn, 1992, Characterisation of ramified microglial cells: detailed morphology, morphological plasticity and proliferative capability, J Anat., 1992, 109
  35. Kempuraj, 2016, Neuroinflammation induces neurodegeneration, J Neurol Neurosurg Spine., 1, 1003
  36. Cohen, 1997, Caspases: the executioners of apoptosis, Biochem J., 326, 1, 10.1042/bj3260001 · DOI · Paper page
  37. Graham, 2011, Caspase-6 and neurodegeneration, Trends Neurosci., 34, 646, 10.1016/j.tins.2011.09.001 · DOI
  38. Han, 2014, Pituitary adenylate cyclase-activating polypeptide is reduced in Alzheimer disease, Neurology., 82, 1724, 10.1212/WNL.0000000000000417 · DOI · Paper page
  39. Alder, 2003, Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity, J Neurosci., 23, 10800, 10.1523/JNEUROSCI.23-34-10800.2003 · DOI · Paper page
  40. Carrette, 2003, A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease, Proteomics., 3, 1486, 10.1002/pmic.200300470 · DOI · Paper page
  41. Selle, 2005, Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease, Comb Chem High Throughput Screen., 8, 801, 10.2174/138620705774962391 · DOI
  42. Antonell, 2013, A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease, Neurobiol Aging., 34, 1772, 10.1016/j.neurobiolaging.2012.12.026 · DOI
  43. Jahn, 2011, Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers, PLoS ONE., 6, e26540, 10.1371/journal.pone.0026540 · DOI · Paper page
  44. Hendrickson, 2015, High resolution discovery proteomics reveals candidate disease progression markers of alzheimer's disease in human cerebrospinal fluid, PLoS ONE., 10, e0135365, 10.1371/journal.pone.0135365 · DOI · Paper page
  45. Fritsche, 2008, Too much linoleic acid promotes inflammation-doesn't it?, Prostagl Leukotri Essent Fatty Acids., 79, 173, 10.1016/j.plefa.2008.09.019 · DOI · Paper page
  46. Kramer, 2002, Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis, Arthr Rheum., 47, 670, 10.1002/art.10803 · DOI
  47. Chang, 2016, Bipolar disorder moderates associations between linoleic acid and markers of inflammation, J Psychiatr Res., 85, 29, 10.1016/j.jpsychires.2016.10.021 · DOI
  48. Calder, 2002, Dietary modification of inflammation with lipids, Proc Nutr Soc., 61, 345, 10.1079/PNS2002166 · DOI · Paper page
  49. Cacabelos, 1994, Brain interleukin-1 beta in Alzheimer's disease and vascular dementia, Methods Find Exp Clin Pharmacol., 16, 141
  50. Bolmont, 2008, Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance, J Neurosci., 28, 4283, 10.1523/JNEUROSCI.4814-07.2008 · DOI · Paper page

Cited by

See all 48

Metadata

Authors
Ma, Q.-L., Zhu, C., Morselli, M., Su, T., Pelligrini, M., Lu, Z., Jones, M., Denver, P., Castro, D., Gu, X., Relampagos, F., Caoili, K., Teter, B., Frautschy, S. A., & Cole, G. M.
Venue
Frontiers in Immunology
Published
2020-10-16
Volume
11
Pages
558036-558036
ISSN
1664-3224 (ISSN-L)
OpenAlex
W3093096604
Cited by
48
References
27
FWCI
1.89
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models. https://app.cochat.ai/papers/10.3389/fimmu.2020.558036
The paper
Ma, Q.-L., Zhu, C., Morselli, M., Su, T., Pelligrini, M., Lu, Z., Jones, M., Denver, P., Castro, D., Gu, X., Relampagos, F., Caoili, K., Teter, B., Frautschy, S. A., & Cole, G. M. (2020). The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2020.558036

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.